142 related articles for article (PubMed ID: 38712535)
1. Functional roles of microRNAs in vasculogenic mimicry and resistance to therapy in human cancers: an update.
García-Hernández AP; Sánchez-Sánchez G; Carlos-Reyes A; López-Camarillo C
Expert Rev Clin Immunol; 2024 May; ():1-14. PubMed ID: 38712535
[TBL] [Abstract][Full Text] [Related]
2. Regulation Networks Driving Vasculogenic Mimicry in Solid Tumors.
Hernández de la Cruz ON; López-González JS; García-Vázquez R; Salinas-Vera YM; Muñiz-Lino MA; Aguilar-Cazares D; López-Camarillo C; Carlos-Reyes Á
Front Oncol; 2019; 9():1419. PubMed ID: 31993365
[TBL] [Abstract][Full Text] [Related]
3. Metastatic breast tumors downregulate miR-145 regulating the hypoxia-induced vasculogenic mimicry.
Contreras-Sanzón E; Carlos-Reyes Á; Sierra-Martínez M; Acosta-Altamirano G; Luna-Rivero C; Núñez-Corona D; García-Hernández AP; Ibarra-Sierra E; Vidrio-Morgado H; Alvarez-Sánchez ME; Marchat LA; López-Camarillo C
Transl Oncol; 2023 Jul; 33():101680. PubMed ID: 37121177
[TBL] [Abstract][Full Text] [Related]
4. Pan-cancer dissection of vasculogenic mimicry characteristic to provide potential therapeutic targets.
Tang H; Chen L; Liu X; Zeng S; Tan H; Chen G
Front Pharmacol; 2024; 15():1346719. PubMed ID: 38694917
[TBL] [Abstract][Full Text] [Related]
5. Dickkopf-1-promoted vasculogenic mimicry in non-small cell lung cancer is associated with EMT and development of a cancer stem-like cell phenotype.
Yao L; Zhang D; Zhao X; Sun B; Liu Y; Gu Q; Zhang Y; Zhao X; Che N; Zheng Y; Liu F; Wang Y; Meng J
J Cell Mol Med; 2016 Sep; 20(9):1673-85. PubMed ID: 27240974
[TBL] [Abstract][Full Text] [Related]
6. An Overview of Vasculogenic Mimicry in Breast Cancer.
Andonegui-Elguera MA; Alfaro-Mora Y; Cáceres-Gutiérrez R; Caro-Sánchez CHS; Herrera LA; Díaz-Chávez J
Front Oncol; 2020; 10():220. PubMed ID: 32175277
[TBL] [Abstract][Full Text] [Related]
7. Vasculogenic Mimicry in Breast Cancer: Clinical Relevance and Drivers.
Morales-Guadarrama G; García-Becerra R; Méndez-Pérez EA; García-Quiroz J; Avila E; Díaz L
Cells; 2021 Jul; 10(7):. PubMed ID: 34359928
[TBL] [Abstract][Full Text] [Related]
8. HypoxamiRs Profiling Identify miR-765 as a Regulator of the Early Stages of Vasculogenic Mimicry in SKOV3 Ovarian Cancer Cells.
Salinas-Vera YM; Gallardo-Rincón D; García-Vázquez R; Hernández-de la Cruz ON; Marchat LA; González-Barrios JA; Ruíz-García E; Vázquez-Calzada C; Contreras-Sanzón E; Resendiz-Hernández M; Astudillo-de la Vega H; Cruz-Colin JL; Campos-Parra AD; López-Camarillo C
Front Oncol; 2019; 9():381. PubMed ID: 31157166
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of melatonin on hypoxia-induced vasculogenic mimicry via suppressing epithelial-mesenchymal transition (EMT) in breast cancer stem cells.
Maroufi NF; Amiri M; Dizaji BF; Vahedian V; Akbarzadeh M; Roshanravan N; Haiaty S; Nouri M; Rashidi MR
Eur J Pharmacol; 2020 Aug; 881():173282. PubMed ID: 32580038
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-204/CREB5 axis regulates vasculogenic mimicry in breast cancer cells.
Contreras-Sanzón E; Palma-Flores C; Flores-Pérez A; M Salinas-Vera Y; B Silva-Cázares M; A Marchat L; G Avila-Bonilla R; N Hernández de la Cruz O; E Álvarez-Sánchez M; Pérez-Plasencia C; D Campos-Parra A; López-Camarillo C
Cancer Biomark; 2022; 35(1):47-56. PubMed ID: 35662106
[TBL] [Abstract][Full Text] [Related]
11. Regulatory mechanisms and therapeutic targeting of vasculogenic mimicry in hepatocellular carcinoma.
Zheng N; Zhang S; Wu W; Zhang N; Wang J
Pharmacol Res; 2021 Apr; 166():105507. PubMed ID: 33610718
[TBL] [Abstract][Full Text] [Related]
12. Epithelial-to-endothelial transition and cancer stem cells: two cornerstones of vasculogenic mimicry in malignant tumors.
Sun B; Zhang D; Zhao N; Zhao X
Oncotarget; 2017 May; 8(18):30502-30510. PubMed ID: 27034014
[TBL] [Abstract][Full Text] [Related]
13. Molecular Mechanisms and Anticancer Therapeutic Strategies in Vasculogenic Mimicry.
Zhang X; Zhang J; Zhou H; Fan G; Li Q
J Cancer; 2019; 10(25):6327-6340. PubMed ID: 31772665
[TBL] [Abstract][Full Text] [Related]
14. Ginsenoside Rg3 suppresses vasculogenic mimicry by impairing DVL3-maintained stemness via PAAD cell-derived exosomal miR-204 in pancreatic adenocarcinoma.
Cai X; Wang Z; Lin S; Chen H; Bu H
Phytomedicine; 2024 Apr; 126():155402. PubMed ID: 38350242
[TBL] [Abstract][Full Text] [Related]
15. Vasculogenic mimicry in carcinogenesis and clinical applications.
Luo Q; Wang J; Zhao W; Peng Z; Liu X; Li B; Zhang H; Shan B; Zhang C; Duan C
J Hematol Oncol; 2020 Mar; 13(1):19. PubMed ID: 32169087
[TBL] [Abstract][Full Text] [Related]
16. Vasculogenic mimicry-associated novel gene signature predicted prognosis and response to immunotherapy in lung adenocarcinoma.
Zhang L; Wu J; Yin WW; Hu J; Liao L; Ma J; Xu Z; Wu S
Pathol Res Pract; 2024 Jan; 253():155048. PubMed ID: 38147724
[TBL] [Abstract][Full Text] [Related]
17. LncRNA PVT1 induces aggressive vasculogenic mimicry formation through activating the STAT3/Slug axis and epithelial-to-mesenchymal transition in gastric cancer.
Zhao J; Wu J; Qin Y; Zhang W; Huang G; Qin L
Cell Oncol (Dordr); 2020 Oct; 43(5):863-876. PubMed ID: 32729021
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of transgelin blocks interleukin-8 utilization and suppresses vasculogenic mimicry in breast cancer cells.
Aikins AR; Kim M; Raymundo B; Kim CW
Exp Biol Med (Maywood); 2017 Mar; 242(6):573-583. PubMed ID: 28058861
[TBL] [Abstract][Full Text] [Related]
19. Role of Bcl-2 and its associated miRNAs in vasculogenic mimicry of hepatocellular carcinoma.
Zhao N; Sun BC; Zhao XL; Wang Y; Meng J; Che N; Dong XY; Gu Q
Int J Clin Exp Pathol; 2015; 8(12):15759-68. PubMed ID: 26884845
[TBL] [Abstract][Full Text] [Related]
20. Stem-like Human Breast Cancer Cells Initiate Vasculogenic Mimicry on Matrigel.
Izawa Y; Kashii-Magaribuchi K; Yoshida K; Nosaka M; Tsuji N; Yamamoto A; Kuroyanagi K; Tono K; Tanihata M; Imanishi M; Onishi M; Sakiyama M; Inoue S; Takahashi R
Acta Histochem Cytochem; 2018 Dec; 51(6):173-183. PubMed ID: 30647492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
